Biomedical application of TiO2NPs can cause arterial thrombotic risks through triggering procoagulant activity, activation and aggregation of platelets
Bian Y, Jin Q, He J, Ngo T, Bae ON, Xing L, Pi J, Chung HY, Xu Y. Biomedical application of TiO2NPs can cause arterial thrombotic risks through triggering procoagulant activity, activation and aggregation of platelets. Cell Biol Toxicol. 2024 Aug 7;40(1):67. doi: 10.1007/s10565-024-09908-y.
Mouse
Cardiovascular diseases
2024
CARD9 protein SUMOylation regulates HOXB5 nuclear translocation and Parkin‐mediated mitophagy in myocardial I/R injury
Li Y, Tang Y, Yan X, Lin H, Jiang W, Zhang L, Zhao H, Chen Z. CARD9 protein SUMOylation regulates HOXB5 nuclear translocation and Parkin-mediated mitophagy in myocardial I/R injury. J Cell Mol Med. 2024 Nov;28(21):e70195. doi: 10.1111/jcmm.70195.
Mouse
Cardiovascular diseases
2024
Leptin drives glucose metabolism to promote cardiac protection via OPA1-mediated HDAC5 translocation and Glut4 transcription
Yang F, He Y, Zhao L, Huang J, Du F, Tian S, Zhang Y, Liu X, Chen B, Ge J, Jiang Z. Leptin drives glucose metabolism to promote cardiac protection via OPA1-mediated HDAC5 translocation and Glut4 transcription. Funct Integr Genomics. 2025 Jan 29;25(1):28. doi: 10.1007/s10142-024-01515-8.
Mouse
Cardiovascular diseases
2025
Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation
Luo Y, Ye T, Tian H, Song H, Kan C, Han F, Hou N, Sun X, Zhang J. Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation. Lipids Health Dis. 2024 Sep 27;23(1):308. doi: 10.1186/s12944-024-02293-9.
Mouse
Cardiovascular diseases
2024
Integrating bioinformatics and ferroptosis to reveal the protective mechanism of Astragaloside IV on chronic heart failure rats
Yuan H, Shi M, Wei J, Liu C, Wang Z, Li Y, Guo Z. Integrating bioinformatics and ferroptosis to reveal the protective mechanism of Astragaloside IV on chronic heart failure rats. Sci Rep. 2024 Sep 6;14(1):20787. doi: 10.1038/s41598-024-72011-z.
Rat
Cardiovascular diseases
2024
Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways
Yan J, Liu H, Shang J, Fang Q, Ye J, Lu X, Fan X. Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways. Heliyon. 2024 Oct 29;10(21):e39939. doi: 10.1016/j.heliyon.2024.e39939.
Rat
Cardiovascular diseases
2024